drugset / Trial / NCT07241065
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy Participants
NaSequentialOpen-labelOther
Summary
The purpose of this study is to assess the effect of capivasertib on the pharmacokinetics of oral dextromethorphan in healthy participants.
Timeline
- Start
- 2026-03-19
- Primary completion
- 2026-06-17
- Completion
- 2026-06-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capivasertib | Small molecule | — | Oral |
| Subject | Dextromethorphan | Unknown | — | Oral |
Indications
No indication recorded.